Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

JPMorgan Chase & Co. (JPM): What You May Be Missing About Wells Fargo & Co (WFC)

The bad news has continued rolling in on the mortgage front. Mortgage applications are falling… fast. Wells Fargo & Co (NYSE:WFC) jumped out first and said it was cutting thousands of jobs in its mortgage department. JPMorgan Chase & Co. (NYSE:JPM) and Bank of America followed suit and said they’re cutting jobs, as well. Heck, even Citigroup is letting some people go related to mortgage lending.

Clearly, this is bad news for banks.

For confirmation, you don’t have to look any further than Wells Fargo & Co (NYSE:WFC)’s second-quarter income statement. During the quarter, the bank raked in an impressive $2.8 billion from its mortgage operations. You can bet that won’t continue in the quarters ahead.

Wells Fargo & Co (NYSE:WFC)But, if you’re a bank investor, none of this should be new to you. We’ve now been talking about rising mortgage rates, and the drop in mortgage applications for months. And even before that, we knew that rock-bottom interest rates, and an epic boom in refinance activity, wasn’t going to last forever.

In all of the fuss over the mortgage-banking slowdown, what may be overlooked is the fact that there’s a heck of a lot more to these banks than just mortgage lending — even when it comes to U.S. mortgage leaders Wells Fargo & Co (NYSE:WFC) and JPMorgan Chase & Co. (NYSE:JPM).

Let’s just focus on Wells here for a minute.

As I mentioned above, during the second quarter, Wells Fargo & Co (NYSE:WFC)’ total mortgage banking fee income was $2.8 billion during the second quarter. Total fee (and other non-interest) income at Wells for the quarter was $10.6 billion. Mortgage banking is a somewhat large fee contributor to Wells’ business, but it’s just one contributor among many. Plus, it’s not like we’re talking about mortgage-banking income going away completely — just falling.

Digging deeper, we can also remind ourselves that Wells Fargo & Co (NYSE:WFC)’ overall business is a lot more than just consumer lending. At the end of the second quarter, Wells’ balance sheet housed $253 billion in one-to-four family mortgage loans, and $439 billion in total consumer loans. But, it also had $189 billion in commercial and industrial loans, and $363 billion in total commercial loans. In all, Wells’ balance sheet isn’t far off from a 50/50 split between commercial and consumer.

As long as we’re thinking about the balance sheet, we might as well remind ourselves that that’s where the other half of Wells Fargo & Co (NYSE:WFC)’ revenue comes from. Higher interest rates will push up what Wells has to pay to borrow money, but that’s unlikely to rise as fast as the rates that the bank collects on the money that it lends. As that plays out, you’ll end up with fatter interest spreads at Wells (yes, and most other banks, too).

Add it all up, and I think we may be at a place that’s advantageous to long-term investors. There’s the clear, well-covered prospect of short-term pain as mortgage-banking fee revenue falls. But there’s the longer-term benefit of wider spreads and more income from lending operations. I have no problem taking advantage of the market’s short term bias… do you?

The article What You May Be Missing About Wells Fargo originally appeared on and is written by Matt Koppenheffer.

Matt Koppenheffer owns shares of Bank of America and JPMorgan Chase & Co. The Motley Fool recommends Bank of America and Wells Fargo. The Motley Fool owns shares of Bank of America, Citigroup Inc, JPMorgan Chase & Co., and Wells Fargo.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!